دورية أكاديمية
Mechanisms of Altered Immune Response in Skin Melanoma.
| العنوان: | Mechanisms of Altered Immune Response in Skin Melanoma. |
|---|---|
| المؤلفون: | Fruntealată RF; Ph.D. Student, University of Medicine and Pharmacy of Craiova, Romania., Marius M; Department of Histology, University of Medicine and Pharmacy of Craiova, Romania., Boboc IKS; Experimental Research Center for Normal and Pathological Aging, University of Medicine and Pharmacy of Craiova, Romania., Mitran SI; Department of Physiology, University of Medicine and Pharmacy of Craiova, Romania., Ciurea ME; Department of Physiology, University of Medicine and Pharmacy of Craiova, Romania., Stoica GA; Department of Pediatric Surgery, University of Medicine and Pharmacy of Craiova, Romania. |
| المصدر: | Current health sciences journal [Curr Health Sci J] 2023 Jul-Sep; Vol. 49 (3), pp. 297-311. Date of Electronic Publication: 2023 Sep 30. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Medical University Publishing House Country of Publication: Romania NLM ID: 101597164 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2067-0656 (Print) NLM ISO Abbreviation: Curr Health Sci J Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: <2013>- : Craiova : Medical University Publishing House Original Publication: Craiova : Editura Medicală Universitară |
| مستخلص: | Melanoma, a deadly form of skin cancer, poses significant challenges to the host immune system, allowing tumor cells to evade immune surveillance and persist. This complex interplay between melanoma and the immune system involves a multitude of mechanisms that impair immune recognition and promote tumor progression. This review summarizes the intricate strategies employed by melanoma cells to evade the immune response, including defective immune recognition, immune checkpoint activation, and the role of regulatory T-cells, myeloid-derived suppressor cells, and exosomes in suppressing anti-tumor immunity. Additionally, we discuss potential therapeutic targets aimed at reversing immune evasion in melanoma, highlighting the importance of understanding these mechanisms for developing more effective immunotherapies. Improved insights into the interactions between melanoma and the immune system will aid in the development of novel treatment strategies to enhance anti-tumor immune responses and improve patient outcomes. Competing Interests: None to declare. (Copyright © 2023, Medical University Publishing House Craiova.) |
| References: | Melanoma Res. 2017 Jun;27(3):200-210. (PMID: 28272106) J Leukoc Biol. 2017 Sep;102(3):601-615. (PMID: 28606939) Cancer Res. 2000 May 15;60(10):2703-9. (PMID: 10825144) Cytokine Growth Factor Rev. 2014 Aug;25(4):377-90. (PMID: 25200249) Nat Rev Immunol. 2008 Jul;8(7):523-32. (PMID: 18566595) J Immunol. 2017 Jan 15;198(2):950-961. (PMID: 28003381) Immunology. 2000 Sep;101(1):90-6. (PMID: 11012758) Blood. 2010 Nov 25;116(22):4501-11. (PMID: 20682852) Science. 2001 Jan 12;291(5502):319-22. (PMID: 11209085) Nature. 2006 Feb 9;439(7077):682-7. (PMID: 16382236) New J Sci. 2014 Jan 5;2014:. (PMID: 24634791) J Invest Dermatol. 2003 Sep;121(3):578-86. (PMID: 12925218) Carcinogenesis. 1997 May;18(5):1013-20. (PMID: 9163689) Cancer Immunol Immunother. 2013 Nov;62(11):1711-22. (PMID: 24072401) Nat Commun. 2019 Jul 26;10(1):3345. (PMID: 31350404) Natl Cancer Inst Monogr. 1978 Dec;(50):179-83. (PMID: 753974) Cell. 2017 Jun 29;170(1):142-157.e19. (PMID: 28648661) Immunity. 1995 Nov;3(5):541-7. (PMID: 7584144) Am J Clin Exp Immunol. 2018 Oct 05;7(5):81-87. (PMID: 30498624) Blood. 2002 May 1;99(9):3326-34. (PMID: 11964300) Cancer Discov. 2019 Oct;9(10):1422-1437. (PMID: 31340937) Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1414-21. (PMID: 11381040) Oncotarget. 2017 Apr 19;8(31):51936-51945. (PMID: 28881701) J Exp Med. 2007 Nov 26;204(12):2977-87. (PMID: 17998387) Nat Commun. 2015 Mar 26;6:6692. (PMID: 25809635) J Leukoc Biol. 1994 Dec;56(6):769-75. (PMID: 7996051) Eur J Immunol. 2003 Nov;33(11):3117-26. (PMID: 14579280) Immunology. 2000 Oct;101(2):169-77. (PMID: 11012769) Clin Cancer Res. 2009 Mar 15;15(6):1931-9. (PMID: 19240164) Cutis. 2004 Nov;74(5 Suppl):4-9. (PMID: 15603215) Cancer Res. 2010 Oct 15;70(20):7788-99. (PMID: 20924102) Cancer Res. 2016 Dec 1;76(23):6964-6974. (PMID: 27671674) Photochem Photobiol Sci. 2018 Dec 5;17(12):1872-1884. (PMID: 29136080) J Transl Med. 2008 Mar 11;6:12. (PMID: 18334033) Curr Opin Immunol. 2018 Apr;51:76-82. (PMID: 29547768) Mol Cell Biol. 2013 Aug;33(16):3091-8. (PMID: 23732914) Clin Cancer Res. 2011 Dec 1;17(23):7230-9. (PMID: 21994414) Trends Immunol. 2001 May;22(5):265-8. (PMID: 11323285) J Immunol. 2017 Feb 1;198(3):1006-1014. (PMID: 28115590) J Immunol. 2013 Dec 15;191(12):5875-84. (PMID: 24218453) Sci Transl Med. 2012 Mar 28;4(127):127ra37. (PMID: 22461641) Blood. 2009 Aug 20;114(8):1537-44. (PMID: 19423728) Clin Cancer Res. 2012 Mar 1;18(5):1207-13. (PMID: 22205687) Nature. 1993 Nov 4;366(6450):76-9. (PMID: 7694153) Clin Cancer Res. 2013 Feb 1;19(3):598-609. (PMID: 23095323) Immunity. 2004 Oct;21(4):503-13. (PMID: 15485628) J Immunol. 2017 Oct 1;199(7):2191-2193. (PMID: 28923980) Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17111-6. (PMID: 21969559) J Dtsch Dermatol Ges. 2014 Nov;12(11):1021-7. (PMID: 25263083) J Immunol. 2016 Mar 15;196(6):2885-92. (PMID: 26864030) J Exp Med. 2000 Oct 2;192(7):1027-34. (PMID: 11015443) Mol Cancer Res. 2018 Feb;16(2):243-255. (PMID: 29117944) J Exp Clin Cancer Res. 2019 Sep 11;38(1):397. (PMID: 31506076) RNA Biol. 2012 Jun;9(6):703-19. (PMID: 22664915) Curr Opin Immunol. 2015 Jun;34:22-7. (PMID: 25597442) Immunity. 1999 Aug;11(2):141-51. (PMID: 10485649) Int J Biochem Cell Biol. 2004 Aug;36(8):1374-9. (PMID: 15147715) Cell Rep. 2016 May 31;15(9):2000-11. (PMID: 27210762) Cancer J. 2014 Jul-Aug;20(4):265-71. (PMID: 25098287) Cancer Res. 2010 Jul 15;70(14):5728-39. (PMID: 20570887) Cancer Res. 2014 Apr 1;74(7):1924-32. (PMID: 24691993) Cancer Res. 2014 Jan 1;74(1):24-30. (PMID: 24220244) Sci Transl Med. 2011 Apr 27;3(80):80ra34. (PMID: 21525398) J Biol Chem. 1996 Oct 25;271(43):26762-71. (PMID: 8900156) Immunity. 2016 Oct 18;45(4):817-830. (PMID: 27760338) Nature. 2018 Aug;560(7718):382-386. (PMID: 30089911) Int J Cancer. 2005 Nov 20;117(4):538-50. (PMID: 15912538) Nat Med. 2003 May;9(5):562-7. (PMID: 12704383) Front Oncol. 2020 Jan 24;9:1512. (PMID: 32039007) Keio J Med. 2005 Dec;54(4):165-71. (PMID: 16452825) Nat Commun. 2017 Jul 24;8:16041. (PMID: 28737175) Science. 1995 Nov 10;270(5238):985-8. (PMID: 7481803) Cancer Metastasis Rev. 2021 Jun;40(2):603-624. (PMID: 33870460) Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):E10672-E10681. (PMID: 30348759) Nat Med. 2010 Oct;16(10):1147-51. (PMID: 20890291) Front Immunol. 2019 Oct 04;10:2298. (PMID: 31636634) J Clin Invest. 2007 Nov;117(11):3383-92. (PMID: 17932562) Nature. 2014 Nov 27;515(7528):563-7. (PMID: 25428504) Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13866-71. (PMID: 11698646) Clin Cancer Res. 2003 Jul;9(7):2551-9. (PMID: 12855630) Nature. 2016 Nov 17;539(7629):437-442. (PMID: 27642729) Cancer Immunol Immunother. 2017 Apr;66(4):523-535. (PMID: 28184968) Science. 2016 Apr 8;352(6282):227-31. (PMID: 26966191) Pathol Oncol Res. 2010 Sep;16(3):303-9. (PMID: 20306313) Cancer Res. 2018 Nov 15;78(22):6349-6353. (PMID: 30442814) Am J Epidemiol. 1994 Oct 15;140(8):691-9. (PMID: 7942771) Blood. 2009 Jun 4;113(23):5811-8. (PMID: 19339692) Cancer Immunol Res. 2017 Jan;5(1):3-8. (PMID: 28052991) Oncogene. 2018 Aug;37(34):4639-4661. (PMID: 29765155) Melanoma Res. 2019 Jun;29(3):237-247. (PMID: 30399061) J Immunol. 2004 Jul 15;173(2):1444-53. (PMID: 15240741) Br J Cancer. 2005 Jan 31;92(2):305-11. (PMID: 15655551) J Exp Med. 2010 Sep 27;207(10):2175-86. (PMID: 20819923) Cancer Res. 2015 Sep 15;75(18):3747-59. (PMID: 26183926) Clin Cancer Res. 2017 Jun 15;23(12):3158-3167. (PMID: 28619999) Annu Rev Immunol. 2016 May 20;34:539-73. (PMID: 26927206) Hum Vaccin Immunother. 2017 Jul 3;13(7):1556-1562. (PMID: 28441072) Cancer Immunol Res. 2018 Oct;6(10):1260-1273. (PMID: 30012633) Hum Immunol. 2010 Oct;71(10):934-41. (PMID: 20650297) Cells. 2019 Jul 02;8(7):. (PMID: 31269655) Front Oncol. 2019 Nov 05;9:1148. (PMID: 31750245) Cancer Res. 2018 Jan 15;78(2):436-450. (PMID: 29150430) J Natl Cancer Inst. 1976 Jul;57(1):211-5. (PMID: 1003502) Exp Eye Res. 2013 Feb;107:52-8. (PMID: 23206928) Lab Invest. 2017 Sep;97(9):1063-1071. (PMID: 28737763) Hum Pathol. 2007 Oct;38(10):1516-25. (PMID: 17640716) Clin Immunol. 2020 Jun;215:108428. (PMID: 32344017) Mol Cell Biol. 2005 Nov;25(21):9543-53. (PMID: 16227604) Nat Med. 2002 Aug;8(8):793-800. (PMID: 12091876) Oncoimmunology. 2014 Dec 15;3(10):e955709. (PMID: 25941575) J Immunol. 2004 Jul 15;173(2):945-54. (PMID: 15240681) Annu Rev Med. 2015;66:97-110. (PMID: 25341012) J Immunol. 1998 Aug 1;161(3):1327-35. (PMID: 9686595) Nat Commun. 2016 Aug 30;7:12632. (PMID: 27572267) Front Oncol. 2018 Jan 23;8:3. (PMID: 29410946) J Immunol. 2000 Jun 15;164(12):6166-73. (PMID: 10843666) Cancer Immunol Immunother. 2012 Dec;61(12):2239-49. (PMID: 22674057) Photodermatol Photoimmunol Photomed. 2018 Jan;34(1):13-24. (PMID: 28703311) Cancers (Basel). 2016 Dec 09;8(12):. (PMID: 27941674) Nature. 2011 Jan 27;469(7331):548-53. (PMID: 21248750) J Invest Dermatol. 2015 Nov;135(11):2785-2793. (PMID: 26121214) Nat Immunol. 2009 Nov;10(11):1185-92. (PMID: 19783989) Magn Reson Med. 2015 Jul;74(1):266-271. (PMID: 25052384) J Exp Med. 2012 Jun 4;209(6):1201-17. (PMID: 22641383) J Invest Dermatol. 2002 Aug;119(2):489-98. (PMID: 12190875) J Immunother Cancer. 2014 May 14;2:13. (PMID: 24855563) Pathology. 2015 Oct;47(6):557-63. (PMID: 26308130) J Surg Res. 2007 Jul;141(1):72-7. (PMID: 17574040) Cytokine. 2018 May;105:63-72. (PMID: 29459345) Sci Rep. 2016 Feb 04;6:20254. (PMID: 26842680) FEBS J. 2013 Nov;280(21):5228-36. (PMID: 23648053) Sci Rep. 2020 Jan 9;10(1):92. (PMID: 31919420) Oncoimmunology. 2012 Oct 1;1(7):1061-1073. (PMID: 23170254) Cell Rep. 2017 May 9;19(6):1189-1201. (PMID: 28494868) J Immunol. 1977 Apr;118(4):1483-7. (PMID: 66296) Photochem Photobiol. 1996 Aug;64(2):254-8. (PMID: 8760564) Blood. 2010 Aug 5;116(5):829-40. (PMID: 20404134) Commun Biol. 2020 Mar 17;3(1):128. (PMID: 32184441) J Immunol. 2012 Dec 15;189(12):5602-11. (PMID: 23152559) Nat Cancer. 2020 Jul;1(7):681-691. (PMID: 35122038) Melanoma Res. 2012 Oct;22(5):327-33. (PMID: 22713796) Cell. 2015 Sep 10;162(6):1242-56. (PMID: 26359984) Sci Rep. 2022 Feb 1;12(1):1701. (PMID: 35105915) J Immunol. 2006 Feb 1;176(3):1375-85. (PMID: 16424164) Cancer Biol Ther. 2019;20(11):1366-1379. (PMID: 31366280) Science. 2018 Mar 23;359(6382):1350-1355. (PMID: 29567705) Nat Immunol. 2001 Mar;2(3):261-8. (PMID: 11224527) J Exp Med. 1991 Sep 1;174(3):561-9. (PMID: 1714933) Cancer Res. 2011 Jun 1;71(11):3792-801. (PMID: 21478294) J Exp Med. 2010 Sep 27;207(10):2187-94. (PMID: 20819927) Front Oncol. 2020 Jul 02;10:951. (PMID: 32714859) Nat Immunol. 2010 Oct;11(10):889-96. (PMID: 20856220) J Immunol. 1998 Apr 1;160(7):3188-93. (PMID: 9531274) J Exp Med. 1997 Feb 3;185(3):393-403. (PMID: 9053440) Cancer Res. 2016 Jan 1;76(1):35-42. (PMID: 26573801) Pigment Cell Melanoma Res. 2015 Jul;28(4):481-4. (PMID: 25963442) Science. 2016 Dec 2;354(6316):1160-1165. (PMID: 27789795) Neoplasma. 2002;49(3):159-66. (PMID: 12098001) Oncoimmunology. 2016 Sep 20;5(11):e1235107. (PMID: 27999753) BMC Immunol. 2011 Mar 18;12:21. (PMID: 21414236) Int J Cancer. 2009 Jun 1;124(11):2621-33. (PMID: 19235923) Melanoma Res. 2016 Oct;26(5):429-41. (PMID: 27455380) Mol Cell Proteomics. 2017 Oct;16(10):1705-1717. (PMID: 28546465) Cell. 2019 Apr 4;177(2):414-427.e13. (PMID: 30951669) J Cancer. 2019 Jun 2;10(11):2578-2587. (PMID: 31258764) Cancer Cell. 2020 Nov 9;38(5):685-700.e8. (PMID: 33007259) Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1549-54. (PMID: 21205892) Clin Cancer Res. 2014 Jul 1;20(13):3446-57. (PMID: 24812408) Science. 1996 Mar 22;271(5256):1734-6. (PMID: 8596936) J Immunol. 2008 Dec 1;181(11):7617-29. (PMID: 19017950) |
| فهرسة مساهمة: | Keywords: Melanoma; immune response; skin cancer |
| تواريخ الأحداث: | Date Created: 20240205 Latest Revision: 20240206 |
| رمز التحديث: | 20240206 |
| مُعرف محوري في PubMed: | PMC10832881 |
| DOI: | 10.12865/CHSJ.49.03.01 |
| PMID: | 38314217 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2067-0656 |
|---|---|
| DOI: | 10.12865/CHSJ.49.03.01 |